Blog | HemaCare

Nancy Andon, MSc


Recent Posts

HemaCare Human Bone Marrow Employed in Groundbreaking Cancer Detection Study

Sep 29, 2020 10:05:00 AM / by Nancy Andon, MSc posted in Bone Marrow, Cancer

0 Comments

A groundbreaking cancer detection study published in Cell [1] cites the use of HemaCare-sourced human bone marrow.

The Cell publication is part of a global collaborative effort based in 8 different countries, including several U.S. based cancer research institutes. Their goal is simple; find a way to detect cancer early, no matter where it originates in the human body, thereby securing the best possible chance of treating patients successfully.

Read More

HemaCare PBMCs Provide Vital Data for CAR T Cell Primate Study

Aug 25, 2020 10:04:00 AM / by Nancy Andon, MSc posted in CAR-T, PBMCs

0 Comments

A recent collaborative study published by Amgen and Kite Pharma cites the use of HemaCare sourced peripheral blood mononuclear cells (PBMC) in their investigative effort on the development of a novel CAR T cell therapy. [1]

Acute myeloid leukemia (AML) is a form of blood cancer characterized by the rapid buildup of abnormal cells in the bone marrow. The disease affects about a million people globally and, tragically, has a less than 30% survival rate.

Read More

HemaCare PBMCs Aid Development of Novel Cancer Immunotherapy

Aug 4, 2020 10:01:00 AM / by Nancy Andon, MSc posted in Cancer, PBMCs, Immunotherapy (Immunology)

0 Comments

A paper published in the journal Blood cites the use of HemaCare-sourced peripheral blood mononuclear cells (PBMCs) to test a murine model of a new antibody-based cancer immunotherapy.

Multiple myeloma (MM) is a life-threatening disease that accounts for 10-15% of all blood-based cancers. The disease occurs when a specific group of white blood cells, known as plasma cells, become malignant. T cell therapy has shown some promise in treating the disease on a temporary basis, but with very few cancer-specific targets identified, MM remains incurable.

Read More

Cryopreserved Leukopaks: Finding the Best Fit for Your Research Needs

Jul 7, 2020 10:03:00 AM / by Nancy Andon, MSc posted in Leukopak, GMP Cellular Therapeutics, Basic Research

0 Comments

The product your lab chooses to fulfill their research needs largely depends on the stage of development. Are you conducting early drug discovery research involving several different candidates? Perhaps your company is involved in translational research, considering a lead candidate for clinical studies? What is your research budget? Choosing the right starting material for a specific project is a critical decision, but one that can sometimes be daunting.

Read More

HemaCare Donor Recruitment Helps Solve Lung Cancer Puzzle

Jun 30, 2020 10:04:00 AM / by Nancy Andon, MSc posted in Cancer

0 Comments

A recent independent study cited using whole blood collected from HemCare donors to carry out research into how lung cancer suppresses the immune system. [1]

Scientists at a Boston-based pharmaceutical company have been trying to puzzle out exactly how lung cancer cells are able to suppress the immune system, and prevent it from launching an effective response. While previous research has exposed cancer-associated fibroblasts (CAFs) as the primary culprits in this process, there is still little real knowledge of how these cells are able to interfere with immune cell function.

Read More

      Subscribe Here!

      Posts by Topic

      see all

      Recent Posts